news.today
Hello · Register today | LoginHello · My Account[—] [33]
UK

Oxford psilocybin depression study reaches final participant

Summarised from 2 outlets · Updated 7 Nov, 20:56 · Archive

The final participant has completed treatment in Oxford's COMP006 study of psilocybin therapy for treatment-resistant depression.

The final participant in the COMP006 study of psilocybin therapy for treatment-resistant depression has completed their last visit at the NIHR Clinical Research Facility at Oxford Health, marking the end of the active delivery phase. The study, which began in 2024, forms part of Compass Pathways' international Phase 3 programme evaluating COMP360 psilocybin therapy.

The study involved treatment sessions, follow-up assessments and long-term monitoring of participants. Interim data released earlier this year showed a statistically significant reduction in depression symptoms six weeks after participants received two doses of 25mg COMP360 compared with the 1mg group.

Dr Katharine Smith, consultant psychiatrist at Oxford Health NHS Foundation Trust and principal investigator for the study, said reaching the final participant visit was 'an important milestone' and described the participants' commitment as invaluable. She noted that further analyses are still ongoing and that completion marked 'the end of a significant phase of work' bringing understanding closer to 'the potential role this investigational treatment may have for people living with treatment-resistant depression'.

Compass Pathways has confirmed ongoing discussions with the US Food and Drug Administration as part of its regulatory submission process. Oxford Health is planning further research into novel treatments for other mental health conditions, including additional psychedelic therapies.

Oxford psilocybin depression study reaches final participant
Image: Oxford Mail

Comments (0)

How it is being reported

In this story: Oxford Health · Compass Pathways · Dr Katharine Smith · US Food and Drug Administration · Oxford

This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log